Literature DB >> 8955438

Clinical and cytofunctional classification of pituitary adenomas: proposal of a new classification.

N Sanno1, A Teramoto, R Y Osamura.   

Abstract

Recent methodological advances in immunohistochemistry, ultrastructural techniques, hormonal assays, resolution imaging and molecular biology techniques have provided new insights into the pathology, function and cytogenesis of pituitary adenomas. Pituitary adenomas have been classified historically on the basis of tinctorial affinities, followed by the basis of ultrastructure and immunohistochemistry. The current development of technologies necessitate the new classification of pituitary adenomas which integrates these numerous parameters as well as the clinical manifestations. For this purpose, we suggest a new clinico-cytofunctional classification of pituitary adenomas, which is based on these clinical manifestations and integrates the information on biology, imaging function and ultrastructure. This classification which corresponds to current advances will not only provide pertinent clinical data but facilitate better understanding of the biology and nature of these complexed lesions.

Entities:  

Mesh:

Year:  1996        PMID: 8955438     DOI: 10.1007/bf01809749

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  17 in total

1.  Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas.

Authors:  S L Asa; B M Gerrie; W Singer; E Horvath; K Kovacs; H S Smyth
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

2.  Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization.

Authors:  R V Lloyd; M Cano; W F Chandler; A L Barkan; E Horvath; K Kovacs
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

3.  Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization.

Authors:  K Kovacs; R Lloyd; E Horvath; S L Asa; L Stefaneanu; D W Killinger; H S Smyth
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization.

Authors:  R V Lloyd; K Fields; L Jin; E Horvath; K Kovacs
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

5.  GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas.

Authors:  N Sanno; A Teramoto; A Matsuno; S Takekoshi; R Y Osamura
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

6.  Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.

Authors:  J Li; L Stefaneanu; K Kovacs; E Horvath; H S Smyth
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 7.  Ultrastructural diagnosis of human pituitary adenomas.

Authors:  E Horvath; K Kovacs
Journal:  Microsc Res Tech       Date:  1992-01-15       Impact factor: 2.769

Review 8.  Pituitary adenocarcinoma in an acromegalic patient: response to bromocriptine and pituitary testing: a review of the literature on 36 cases of pituitary carcinoma.

Authors:  R B Mountcastle; B S Roof; R K Mayfield; D B Mordes; J Sagel; P J Biggs; S E Rawe
Journal:  Am J Med Sci       Date:  1989-08       Impact factor: 2.378

9.  Monomorphous plurihormonal adenoma of the human pituitary. A histologic, immunocytologic and ultrastructural study.

Authors:  D J McComb; T A Bayley; E Horvath; K Kovacs; I A Kourides
Journal:  Cancer       Date:  1984-04-01       Impact factor: 6.860

10.  In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas.

Authors:  L Stefaneanu; K Kovacs; E Horvath; R V Lloyd
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991
View more
  2 in total

1.  Molecular Pathology of the Pituitary Adenomas.

Authors:  Naoko Sanno; Robert Y. Osamura
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

2.  Expression of MSX1 in human normal pituitaries and pituitary adenomas.

Authors:  Yoshihito Mizokami; Noboru Egashira; Susumu Takekoshi; Johbu Itoh; Yoshiko Itoh; Robert Yoshiyuki Osamura; Mitsunori Matsumae
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.